Late phase research has changed substantially over the past decade. During this period of innovation and development, many myths and misconceptions about late phase research have surfaced regarding study design, outsourcing, preferred provider access, and scientific value, just to name a few. Throughout this series, a panel of post-marketing experts with diverse backgrounds in late phase research will define and disprove these myths. Join PRA Health Sciences' Maria Harrison, Vice President of Late Phase Services, in an introduction to our 10-part podcast series "Dispelling Late Phase Myths and Misconceptions" as she discusses the rationale behind these myths as well as the content that will be covered in upcoming podcasts.
Challenging Study Timeline Goals Achieved in Global Post-Authorization Safety Study (PASS)
PRA Health Sciences Late Phase Services is participating in a global real world safety study program, mandated by various regulatory bodies, to…
PRA in China
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.
THE INSIGHT SERIES: Do Late Phase Studies Offer Any Scientific Value? – Part 2
The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these…